Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.03 CHF | +0.32% | -1.98% | +8.44% |
11:15am | Novartis: positive phase III results in C3G | CF |
10:15am | Novartis: presented results for kidney disease | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.44% | 205B | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
-5.97% | 203B | |
+6.19% | 164B | |
+0.31% | 164B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : UBS maintains a Buy rating